Browse the full directors' dealings record of REINSURANCE GROUP OF AMERICA INC, a listed equity based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Operating in the Insurance sector, REINSURANCE GROUP OF AMERICA INC has recorded 8 reports. The latest transaction was disclosed on 29 December 2021 (Cession). Among the most active insiders: GAUTAM ALKA. The full history is openly available.
0 of 0 declarations
Reinsurance Group of America, Incorporated (NYSE: RGA) is a U.S.-based global leader in life and health reinsurance. The company was formed on December 31, 1992 and has since built a highly specialized franchise focused on biometric risk, longevity risk, and capital-oriented solutions. RGA’s principal executive office is in Chesterfield, Missouri, near St. Louis, and its operating footprint spans the United States, Latin America, Canada, Europe, the Middle East, Africa, Asia, and Australia. ([rgare.com](https://www.rgare.com/docs/default-source/investor-relations/rga-10k-2024.pdf)) RGA’s business model is anchored in two core pillars: traditional reinsurance and financial solutions. Traditional reinsurance covers individual and group life, health, disability, and critical illness lines. Financial solutions include longevity reinsurance, asset-intensive products, primarily annuities, financial reinsurance, capital solutions, and stable value products. In practical terms, RGA helps cedants reduce net risk exposure, improve balance sheet flexibility, smooth earnings volatility, and support regulatory capital management. That positioning makes RGA a strategic partner to insurers rather than just a provider of capacity. ([rgare.com](https://www.rgare.com/docs/default-source/investor-relations/rga-10k-2024.pdf)) From a competitive standpoint, RGA is one of the most recognized global reinsurers focused primarily on life and health. Its edge lies in deep actuarial expertise, underwriting discipline, and the ability to structure and execute large in-force transactions. The company also emphasizes its global platform and strong client relationships, which support cross-border deal flow and product development. In February 2025, RGA announced a reinsurance transaction with Equitable Holdings involving a diversified block of life insurance products worth $32 billion, underscoring its ability to deploy capital at scale. In June 2025, RGA said it had ranked #196 on the Fortune 500, moving up 27 places year over year. ([nasdaq.com](https://www.nasdaq.com/press-release/rga-announces-reinsurance-transaction-equitable-holdings-2025-02-24)) For French-speaking investors, the key investment appeal sits in RGA’s defensive profile within the Insurance sector, its geographic diversification, and the recurring demand for life and health reinsurance capacity. In 2025, management highlighted strong operating momentum, improved deployable capital, and a higher quarterly dividend. By early 2026, the company said its financial metrics were tracking at or ahead of its strategic targets launched in 2023, which suggests solid execution and capital discipline. As a U.S.-listed NYSE company, RGA offers exposure to structural demand for risk transfer in life and health insurance, with earnings sensitivity to transaction volumes, mortality/morbidity experience, and capital market conditions. ([rgare.com](https://www.rgare.com/our-company/media/press-releases/press-releases-detail/2025/07/31/reinsurance-group-of-america-reports-second-quarter-results?utm_source=openai))